Navigation Links
Vygone Presents A New Product To Deal With Genital Warts And Other Herpes Virus Related Skin Problems
Date:7/2/2012

SPRINGVILLE, UTAH (PRWEB) July 02, 2012

Recent studies have shown millions of people in the US are suffering from genital warts. Genital Warts infection is caused by the herpes virus which is transmitted through direct skin contact, especially during sexual intercourse. Symptoms of virus infection appear after a few days and most people don’t realize immediately when they are infected. The genital warts virus is 100,000 times smaller than a single cell and it cannot be killed easily. Vygone has introduced its new Inhibitor Zapper to provide relief to people who need effective genital warts treatment.

Symptoms of Genital Warts infection include blisters and lesions in the genital area coupled with painful itching, burning in genital area as well as the appearance of small red bumps. Usually, symptoms occur after 2 to 10 days of viral attack. Pain can also occur in the buttocks and legs. The genital area of the sufferer may also become painful, especially when urinating. Other symptoms include blisters, vaginal discharge, open lesions and vaginal pressure. Some people also experience stomach pain, flu, fevers and head ache when they get infected by this virus.

Unfortunately, herpes virus cannot be treated easily. But Vygone’s Zapper provides a safe way to treat herpes symptoms. This treatment has helped a lot of people who are infected with this unwanted disease. Application of the VyGone Inhibitor Zapper at the initial stage of the infection has been proven to help to prevent forming of lesions and sores. Using the electro waveform technology, the VyGone Inhibitor Zapper can treat the symptoms of herpes successfully. Upon application on the infected area, the electro waveform from the VyGone Zapper can halt the activities of the virus and eliminate those embarrassing symptoms.

The new Zapper from Vygone is also a harmless and non-invasive product that provides a safe way to cure genital warts. It does not have any chemical elements and is non-addictive with no known side-effects. It is designed to be portable so that it can be conveniently used during a genital warts attack. When used consistently, it can certainly lessen the duration and seriousness of the viral attacks. More information about the product can be obtained at the official site: http://www.Vygone.com.

Read the full story at http://www.prweb.com/releases/2012/7/prweb9652295.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. VyGone Inhibitor Zapper: The Brand New Solution For the Safe Treatment Of Sores, Warts and Herpes
2. Vygone Introduces A New Zapper For Effective Relief From Herpes Virus Related Skin Problems
3. Vygone Presents a Revolutionary Electro Waveform Device to Help Treat Molluscum Contagiosum Lesions
4. Gene Signal presents data at ARVO 2012 showing topical aganirsen is active in retinal disease
5. Mount Sinai presents treatment trends, vaccine research, prognosis data at ASCO
6. AGA presents cutting-edge research during DDW®
7. SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston
8. Researchers find evidence of banned antibiotics in poultry products
9. Pig stomach mucins are effective as anti-viral agents for consumer products
10. Moffitt researchers find adolescents with cancer concerned about their future reproductive health
11. Probiotic Products May Prevent Antibiotic-Linked Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... ... engineers, and scientists from around the world, announces the launch of its newly ... and easy portal to research breakthroughs and trending news, vital information on upcoming ...
(Date:1/19/2017)... ... January 19, 2017 , ... Remote ... recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound System. ... to RMT technology that delivers HD, dynamic, streaming ultrasound images and video to ...
(Date:1/19/2017)... ... January 19, 2017 , ... WholeHealth is ... year. Drs. Alexander Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus will be present Saturday ... clinic’s leading recovery program. , “We know it’s easy to get carried ...
(Date:1/19/2017)... Scotch Plains, NJ (PRWEB) , ... January 19, ... ... a board certified dermatologist by the American Board of Dermatology and fellowship trained ... Institute of the National Institutes of Health, Dr. Li completed his internship in ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... Clinical Conductor CTMS, which provides a modern CTMS workflow designed to seamlessly integrate ... information has been condensed to a single page, maximizing usability and improving efficiency ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 Agonists, ... Others The global anti-obesity drugs market is ... half of the forecast period and CAGR of 38.7% in the ... grow at a CAGR of 32.8% from 2016 to 2027. The ... 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... 2017 James Gilbart ... Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European Oncology ... an article by James Gilbart and ...
(Date:1/19/2017)... , Jan. 19, 2017   Science Exchange , ... to announce that the first five replication studies ... have been published in eLife today. Despite intense ... the first practical evaluation of reproducibility rates that ... studies. Unlike other assessments of reproducibility, the results ...
Breaking Medicine Technology: